Effect of hematin in porphyric neuropathy

Neurology

Volumn 27, Issue 11, 1977, Pages 1053-1056

  Bosch, E Peter ^a   Pierach, Claus A ^b   Bossenmaier, Irene ^b   Cardinal, Ruth ^b   Thorson, Mark ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; AMOBARBITAL; ATROPINE; CHLORPROMAZINE; CLORAZEPATE; CYTOCHROME P450; DEXTROPROPOXYPHENE; HEMATIN; HYOSCYAMINE; IMIPRAMINE; PHENOBARBITAL; PORPHOBILINOGEN; SECOBARBITAL; TRIFLUOPERAZINE; UNCLASSIFIED DRUG; UROPORPHYRINOGEN SYNTHASE;

ARTICLE; DIAGNOSIS; DRUG BLOOD LEVEL; DRUG THERAPY; NEUROPATHY; PORPHYRIA; REVIEW; SERUM; THERAPY;

ADULT; FEMALE; HEME; HEMIN; HUMANS; PERIPHERAL NERVOUS SYSTEM DISEASES; PORPHYRIAS;

EID: 0017717021     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/wnl.27.11.1053     Document Type: Article

References (28)

1. Waldenström J: The porphyrias as inborn errors of metabolism. Am J Med 22:758-773, 1957
2. Stein JA, Tschudy DP: Acute intermittent porphyria. A clinical and biochemical study of 46 patients. Medicine 49:1-16, 1970
3. Meyer UA, Schmid R: Intermittent acute porphyria: The enzymatic defect. In Plum F (Editor): Brain Dysfunction in Metabolic Disorders. New York, Raven Press, 1974, pp 211-224
4. Tschudy DP, Valsamis M, Magnussen CR: Acute intermittent porphyria: Clinical and selected research aspects. Ann Intern Med 83:851-864, 1975
5. Granick S: The induction in vitro of the synthesis of delta-aminolevulinic acid synthetase in chemical porphyria: A response to certain drugs, sex hormones, and foreign chemicals. J Biol Chem 241:13591375, 1966
6. Tschudy DP, Welland FH, Collins A, et al: The effect of carbohydrate feeding on the induction of delta-aminolevulinic acid synthetase. Metabolism 13:396-406, 1964
7. Welland FH, Heilman ES, Gaddis EM, et al: Factors affecting the excretion of porphyrin precursors by patients with acute intermittent porphyria: I. The effect of diet. Metabolism 13:232-250, 1964
8. Watson CJ, Dhar GJ, Bossenmaier I, et al: Effect of hematin in acute porphyric relapse. Ann Intern Med 79:80-83, 1973
9. Dhar GJ, Bossenmaier I, Petryka ZJ, et al: Effects of hematin in hepatic porphyria: Further studies. Ann Intern Med 83:20-30, 1975
10. Watson CJ: Hematin and porphyria. N Engl J Med 293:605-606, 1975
11. Watson CJ, Pierach CA, Bossenmaier I, et al: Use of hematin in the acute attack of the “inducible hepatic porphyrias.” Adv Intern Med, vol 23, 1978 (In press)
12. Peterson A, Bossenmaier I, Cardinal R, et al: Hematin treatment of acute porphyria. Early remission of an almost fatal relapse. JAMA 235:520-522, 1976
13. Watson CJ, Taddeini L, Bossenmaier I: Present status of the Ehrlich aldehyde reaction for urinary porphobilinogen. JAMA 190:501-504, 1964
14. Miyagi K, Cardinal R, Bossenmaier I, et al: The serum porphobilinogen and hepatic porphobilinogen deaminase in normal and porphyric individuals. J Lab Clin Med 78:683-695, 1971
15. Mauzerall D, Granick S: Occurrence and determination of delta-aminolevulinic acid and porphobilinogen in urine. J Biol Chem 219:435-446, 1956
16. Strand LJ, Meyer UA, Felsher BF, et al: Decreased red cell uroporphyrinogen I synthetase activity in acute intermittent porphyria. J Clin Invest 51:2530-2536, 1972
17. Goldberg A: Acute intermittent porphyria: A study of 50 cases. Q J Med 28:183-209, 1959
18. Ridley A: The neuropathy of acute intermittent porphyria. Q J Med 38:307-333, 1969
19. Sorenson AWS, With TK: Persistent pareses after porphyric attacks. Acta Med Scand 190:219-222, 1971
20. Cavanagh JB, Mellick RS: On the nature of the peripheral nerve lesions associated with acute intermittent porphyria. J Neurol Neurosurg Psychiatry 28:320-327, 1965
21. Feldman DS, Levere RD, Lieberman JS, et al: Presynaptic neuromuscular inhibition by porphobilinogen and porphobilin. Proc Natl Acad Sci USA 68:383-386, 1971
22. Kramer S, Viljoen D, Becker D, et al: A possible explanation for the neurological disturbances in the porphyrias. S Afr J Lab Clin Med 17:103-105, 1971
23. Scott JJ: The metabolism of delta-aminolaevulinic acid. In Wolstenholme GEW, Millar ECP (Editors): Ciba Foundation Symposium on Porphyrin Biosythesis and Metabolism. Boston, Little Brown and Company, 1955, pp 43-59
24. Kramer S, Becker D, Viljoen D: Significance of the porphyrin precursors delta-aminolaevulinic acid (ALA) and porphobilinogen (PBG) in the acute attack of porphyria. S Afr Med J 47:1735-1738, 1973
25. Cavanagh JB, Ridley AR: The nature of the neuropathy complicating acute intermittent porphyria. Lancet 2:1023-1024, 1967
26. De Matteis F, Rimington C: The biochemical disturbance in acute intermittent and experimental porphyria. Lancet 1:1332-1334, 1962
27. Irvine DG, Wetterberg L: Kryptopyrrole-like substance in acute intermittent porphyria. Lancet 2:1201, 1972
28. Correia MA, Meyer UA: Apocytochrome P-450: Reconstitution of functional cytochrome with hemin in vitro. Proc Natl Acad Sci USA 72:400-404, 1975